Paul Lawrence, Harvard Business School professor, dies at 89

The pioneering professor at Harvard Business School died November 1 at age 89.

Paul Lawrence, M.B.A. ’47, D.C.S. ’50, a Harvard Business School professor whose work on a unifying theory of organizational behavior was the subject of an article in the September-October issue of this magazine, died November 1 at the age of 89. The Donham professor of organizational behavior emeritus at the time of his death, Lawrence was a leading scholar in his field, the author of 26 books and countless articles.

An obituary appears on the Harvard Business School website.

You might also like

Creepy Crawlies and Sticky Murder Weapons at Harvard

In the shadows of Singapore’s forests, an ancient predator lies in wait—the velvet worm.

Harvard’s Endowment, Donations Rise—but the University Runs a Deficit

The annual financial report signals severe challenges to come.

Harvard Alum Wins Economics Nobel Prize

Philippe Aghion helped show how “creative destruction” drives growth.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

The Teen Brain

It’s a paradoxical time of development. These are people with very sharp brains, but they’re not quite sure what to do with them...

Explore More From Current Issue

Students in purple jackets seated on chairs, facing away in a grassy area.

A New Prescription for Youth Mental Health

Kenyan entrepreneur Tom Osborn ’20 reimagines care for a global crisis.

Three book covers arranged in a row on a beige background with a red border.

Must-Read Harvard Books Winter 2025

From aphorisms to art heists to democracy’s necessary conditions 

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.